Interview with Gordan Lauc for Next Human
Understanding Glycosylation and Aging
Next Human: Your work focuses on understanding the relationship between glycosylation and aging. Could you explain how changes in glycosylation patterns impact aging and longevity?
Gordan Lauc: Glycans change significantly with age, correlating with shifts in inflammation. When people are young, their glycans generally suppress inflammation, but as they age, glycans begin promoting it. While we don’t yet have definitive proof that changing glycans directly suppresses inflammation, there are indications that certain interventions—like young immunoglobulin transfusions—may help reduce inflammation.
This chronic, low-grade systemic inflammation, or “inflammaging,” contributes to tissue damage over time. Normally, inflammation is a necessary immune response to threats, but as we age, our ability to regulate it diminishes. Instead of acute bursts of inflammation that resolve, older individuals experience persistent, low-level inflammation that damages tissues, consumes energy, and accelerates aging.
Biomarkers and Early Detection of Age-Related Diseases
Next Human: How does the study of biomarkers in your research open up new possibilities for early detection of age-related diseases and personalized health interventions?
Gordan Lauc: Medicine today often relies on standardized treatments that don’t account for individual differences. We know that people respond differently to drugs, diets, and lifestyle interventions, yet we lack precise ways to determine what works for each person.
Glycans offer a dynamic biomarker that responds to lifestyle changes, diet, and interventions. Unlike genetic or epigenetic tests, which remain relatively stable, glycan patterns shift based on one’s health trajectory. For example, glycans can indicate a predisposition to insulin resistance up to seven years before the onset of diabetes. Instead of waiting for a disease to develop, we can detect early warning signs and take preventive action through lifestyle modifications, dietary changes, or targeted interventions.
Integrating Systems Biology, Genomics, and Aging
Next Human: Your research integrates systems biology with genomics and aging. How do you see these fields converging to create a more comprehensive understanding of human health and longevity?
Gordan Lauc: We still don’t fully understand life at the molecular level. Our goal is to integrate measurable biological data—genomics, metabolomics, proteomics, and glycomics—and apply AI-driven analysis to interpret complex interactions.
Glycosylation is particularly interesting because it bridges genetic information, epigenetic regulation, and environmental influences. By analyzing glycans, we can assess genetic predispositions, past exposures, and lifestyle impacts all at once. Psychological well-being, stress, sleep, and diet all affect glycan profiles, making them a powerful tool for understanding aging and health trajectories.
Surprising Findings in Longevity Research
Next Human: What are the most surprising or unexpected findings in your research that could change the way we think about longevity and aging?
Gordan Lauc: We still debate whether aging is a programmed process or simply the accumulation of damage. Evolution may have favored aging as a way to remove older individuals to allow for adaptation in younger generations. IgG glycosylation might play a role in this process.
Interestingly, research has shown that molecules from young organisms can rejuvenate older ones. For example, exosome fractions from newborn blood plasma have extended lifespan in rats by 50%, significantly reducing their biological age markers. This suggests that factors in young blood can influence aging, though applying this insight to humans is complex.
Another major breakthrough is our ability to track glycan age with high precision. Unlike epigenetic age tests, which have significant measurement variability, glycan tests offer a reliable way to assess biological age and monitor the impact of interventions over time.
Promising Research Areas in Longevity Science
Next Human: There’s been a surge in interest in longevity research. What are the most promising areas that could have the biggest impact on the longevity industry in the coming years?
Gordan Lauc: We are beginning to understand the biological mechanisms that drive aging, though much of this research is still based on animal models. The combination of multi-omics data collection with AI-driven analysis will be crucial.
Drug repurposing is another promising area. While no single longevity drug will work for everyone, identifying targeted interventions based on individual biomarkers can have a profound impact. Personalized medicine is key—rather than taking dozens of supplements blindly, we need better ways to determine which interventions are beneficial for each person.
Key Actionable Steps for Longevity
Next Human: Based on the latest research, what key steps should people take today to improve their longevity?
Gordan Lauc: The best advice remains what our grandmothers told us: eat healthy, exercise moderately, get enough sleep, and manage stress. Ultra-processed foods, excessive sugar, and a sedentary lifestyle are major contributors to accelerated aging.
Personalized monitoring—using tools like glycan testing—allows individuals to track changes over time and make informed decisions. By identifying early risk factors and adjusting lifestyle habits accordingly, we can extend healthspan and delay the onset of age-related diseases.
Interview with Gordan Lauc for Next Human
Common Misconceptions About Longevity Research
Next Human: What are some common misconceptions people have about longevity research, and what should individuals be more aware of when considering lifestyle changes based on emerging science?
Gordan Lauc: One of the most common misconceptions about longevity is that its primary goal is to make people live forever. While some individuals might aspire to that, the true aim of longevity research is to maximize health span—to help people live as long as possible while maintaining good health. The actual number of years—whether it’s 70, 100, or 150—is less significant than ensuring a high quality of life. Nobody wants to live long if they are suffering.
The Role of Genetics, Molecular Pathways, and Interventions
Next Human: Are there specific genes, molecular pathways, or interventions that you believe hold significant promise for the future?
Gordan Lauc: At this moment, I see all currently available interventions as high-risk because we do not fully understand their long-term effects. Take Metformin, for example. Many longevity researchers, including David Sinclair and Tim Spector, take it. I tried it myself for six months and monitored changes in my GlycanAge, but the effect was zero. We then conducted a proper placebo-controlled randomized trial, where only one person out of the entire cohort showed a beneficial response to Metformin. While Metformin can be highly effective for individuals with prediabetes or diabetes, its benefits for healthy individuals remain questionable. The same goes for many supplements—most do not show significant effects in the majority of people. It’s crucial to monitor yourself and see if an intervention truly benefits you.
The Science and Uncertainty Around NAD+
Next Human: What are your thoughts on NAD+ and its role in longevity?
Gordan Lauc: NAD+ is undoubtedly a crucial molecule involved in energy metabolism, but we lack solid evidence that taking NAD+ supplements significantly increases intracellular NAD+ levels or improves longevity. Without proper studies, we cannot conclude whether it is effective for everyone. We are currently planning a large placebo-controlled trial with a supplement company to rigorously test these claims.
Ethical Considerations and Equitable Access
Next Human: What are the ethical implications of longevity research and the use of genetic and molecular data to extend life? How can the industry ensure equitable access?
Gordan Lauc: Over time, these interventions will become more affordable. Right now, they are expensive because they cater to a niche market, but mass adoption will drive costs down. However, the real challenge is that companies seek a universal longevity drug, which is unlikely to exist. We need personalized approaches, combining biomarker panels to stratify individuals and targeted interventions tailored to their specific needs.
Predictions for Aging Research in the Next Decade
Next Human: What are your predictions for the next five to ten years in aging research? Are there any game-changing discoveries on the horizon?
Gordan Lauc: Distinguishing between real scientific breakthroughs and hype is difficult. Many companies survive by convincing investors they have a magic cure. However, there is a positive shift toward rigorous science, validating interventions, and establishing standards. Currently, no intervention has been definitively proven to work for everyone. Also, we are seeing a stagnation in lifespan extension. In some places, like the U.S., life expectancy has plateaued or even declined due to lifestyle factors. The key to progress is large-scale research, replication, and validation of interventions, so people can trust the field more.
Biomarkers and Their Role in Health Optimization
Next Human: How does your work on biomarkers of aging align with the broader goal of maintaining quality of life as we age?
Gordan Lauc: We focus on glycans as biomarkers. We initially studied them in the context of disease detection and patient stratification. Glycans are highly indicative of inflammation and metabolic health. If we measure them early and detect unfavorable changes, individuals can intervene in their lifestyle before developing diseases. The goal is to prevent illness rather than treat it after symptoms appear. Biomarkers help us monitor these changes before they become clinically apparent.
Staying Informed in the Rapidly Evolving Longevity Field
Next Human: For individuals passionate about longevity and health optimization, what are the best resources—scientific literature, organizations, or tools—to stay informed and proactive?
Gordan Lauc: Keeping up with scientific literature is incredibly difficult, but AI tools are making it easier to distill information. Tools like ChatGPT provide helpful summaries, though verification is still necessary. Many researchers and media outlets are also working on curating reliable longevity-related content. AI-driven interpretation of personal health data will likely play a major role in the future.
Inteview with Nikolina Lauc for Next human
“Decoding Longevity: How Glycans Unlock the Future of Personalized Aging”
Next human: Your lab is based on cutting-edge research at your facility in Zagreb. Can you share some recent findings or advancements that are pushing the boundaries of aging research?
Nikolina Lauc: One of the most interesting recent focuses has been on menopause. We’ve always known that men and women age differently, with women’s immune systems aging slightly slower than men’s. However, as women transition into menopause, they often experience a rapid increase in inflammation. This state of chronic inflammation can persist for over a decade but is both preventable and treatable with estrogen.
Estrogen has a significant impact on longevity and is likely one of the first validated longevity drugs we have. It has been in medical practice for over 56 years, and we have extensive long-term data showing its benefits. Studies have confirmed that estrogen prolongs lifespan, reduces all-cause mortality, and delays the onset of numerous age-related conditions. A recent study from the UK Biobank, analyzing data from 500,000 people, identified 14 routinely prescribed drugs that prolong lifespan—four of which were estrogens. We’re now exploring how to optimize estrogen therapy in terms of timing and dosage.
Next human: How is your lab using big data and advanced analytics to refine and improve the GlycanAge biomarker? What’s next in terms of scientific progress?
Nikolina Lauc: We were the first in the world to analyze the human glycome at scale. Our lab in Zagreb currently processes more human glycan data than the rest of the world combined—representing about 83% of global glycan research.
Even with this leadership in data, the field is still young. We’ve analyzed around 250,000 samples from various biobanks and clinical studies worldwide. Although our core algorithm was developed nearly 15 years ago, we have deliberately kept it unchanged to maintain consistency in longitudinal tracking. However, we continue to improve personalization and refine how different glycans correlate with disease traits and interventions.
Next human: How does your research on glycans help uncover the mechanisms of aging? Are there any groundbreaking discoveries that could influence future longevity treatments?
Nikolina Lauc: Our biomarker was discovered somewhat accidentally. While analyzing glycans at scale, we realized that understanding aging is crucial to understanding disease. Aging itself turned out to be a bigger determinant than previously thought.
We now know that biological age, which reflects health status, can differ significantly from chronological age. A 40-year-old could have the biological age of a 20-year-old, or conversely, they could be biologically 60. This difference directly impacts mortality and morbidity risks.
A key driver of this process is “inflammaging,” or the gradual accumulation of immune system damage over time. This is highly influenced by lifestyle factors, meaning it’s both measurable and modifiable. Our research shows that a younger glycan age correlates with a reduced mortality risk, while an older glycan age indicates a higher risk.
Next human: Many therapies that impact longevity seem to affect the immune system. How do you view the relationship between immune aging and overall aging?
Nikolina Lauc: Aging is a complex process, and while immune aging is not the only factor, it is certainly one of the most critical. The immune system is the body’s primary defense mechanism, and its health influences a vast number of diseases.
Some of the most promising longevity therapies target immune function. Whether it’s through lifestyle interventions, hormone replacement, or other emerging therapies, maintaining immune health is essential for extending both lifespan and healthspan.
Next human: Collaboration is a vital part of scientific progress. How does your lab work with other institutions or industry partners to expand the understanding and application of GlycanAge?
Nikolina Lauc: Collaboration is at the heart of our work. Validating findings across different populations is essential, and we’ve partnered with researchers worldwide. One of our earliest initiatives, the Human Glycome Project, examined aging across 31 different populations to determine whether glycan aging patterns were consistent globally.
Interestingly, one of the strongest predictors of glycan age is expected lifespan. Our research showed that certain populations age differently, and environmental factors play a significant role in this process. By working with global cohorts, we can refine our understanding of aging and develop more targeted interventions.
Next human: What do you see as the most exciting future applications of glycan-based research in longevity and precision medicine?
Nikolina Lauc: The future of glycan-based research is incredibly promising. We’re moving towards a more personalized approach to aging, where interventions are tailored to an individual’s biological profile rather than one-size-fits-all recommendations.
We envision glycans being used not only as biomarkers but also as therapeutic targets. Understanding how they influence aging allows us to develop interventions that slow or even reverse biological age. This could include everything from lifestyle modifications to pharmaceutical treatments aimed at optimizing immune health and reducing chronic inflammation.
Next human: Thank you, Nikolina. This has been a fascinating discussion. Any final thoughts?
Nikolina Lauc: Thank you! My final message would be that aging is not an inevitable decline—it’s something we can influence. By understanding our biological age and taking proactive steps, we can lead longer, healthier lives. The science is evolving rapidly, and I’m excited about what’s ahead.
Interview with Paula Francekovic – Educational Manager at GlycanAge
,,GlycanAge helps individuals make informed decisions today that will benefit their future well-being“
Next Human: Once an individual has taken the GlycanAge test, what recommendations or insights can they take from this information to optimize their health?
Paula: The GlycanAge test can be used in two ways. You can order it directly from our website, or you can work with clinical practices that offer GlycanAge testing as part of their protocols. In both cases, you are guided by experts who help interpret the results. Understanding glycan data can be complex, so working with a specialist ensures that you receive actionable insights tailored to your individual health profile.
We focus on measuring and controlling a key aspect of aging called ‘inflammaging.’ Managing inflammation is crucial for improving one’s GlycanAge. This can be achieved through an anti-inflammatory diet, optimizing exercise routines, and managing chronic stress exposure. Stress is a major factor affecting aging due to modern lifestyles, and even loneliness has been linked to immune system function. Interestingly, exercise must be balanced—both sedentary lifestyles and excessive training can lead to pro-inflammatory responses. Identifying an individual’s ‘Goldilocks zone’ for exercise is essential.
Next Human: What has the response been like from users who have taken the GlycanAge test? Are there any success stories where the test has helped individuals make impactful health changes?
Paula: We have many success stories, which is one of the most rewarding aspects of my work. Many individuals seek GlycanAge testing after struggling to find answers for unexplained fatigue or feeling ‘off.’ Traditional medicine may not always detect early-stage issues, but our test can reveal early signs of inflammatory imbalances.
A common example is women in perimenopause. This transitional period can last several years, making it difficult for women to determine whether symptoms are due to menopause, stress, or other factors. GlycanAge helps provide clarity, allowing them to seek appropriate therapies and lifestyle changes that improve their well-being.
Next Human:: How often should someone retake the GlycanAge test to track changes in their biological age? Can it be used for long-term health monitoring?
Paula: The frequency of testing depends on the individual’s health goals. If someone is starting a new medication or hormone replacement therapy, we typically see changes within three months. For dietary or exercise interventions, noticeable shifts occur around the six-month mark. If the goal is general immune health monitoring, an annual test is sufficient.
Next Human: How do you envision the future of longevity and anti-aging technology?
Paula: At GlycanAge, our vision is to contribute to the development of personalized preventative healthcare. I believe the future lies in truly personalized medicine, where we can intervene at the earliest stages of disease development. By targeting aging mechanisms before they become diseases, we can extend both healthspan and lifespan. Glycans play a crucial role in this approach, as they provide deep insights into individual differences in aging and immunity.
Next Human: What do you hope people take away from using GlycanAge? Is it about awareness, prevention, or motivation for lifestyle changes?
Paula: It’s a mix of all three. GlycanAge serves as a powerful tool to help people reflect on their aging process and mortality. While this can be intimidating, it also opens up a dialogue with one’s future self—what kind of life do you want in 10, 20, or 30 years? GlycanAge helps individuals make informed decisions today that will benefit their future well-being.
Next Human: For those looking to optimize their health and extend their healthspan, what are the most common mistakes you see people making? How does GlycanAge help them avoid these pitfalls?
Paula: We work with many biohackers who experiment with longevity protocols and use GlycanAge to evaluate their effectiveness. One common mistake is over-exercising. As mentioned earlier, there is an optimal range of exercise for longevity, and excessive training without proper recovery can be counterproductive.
Another mistake is excessive reliance on longevity supplements. Many people take 20 or more supplements, believing they are boosting their longevity. However, many of these compounds work through a process called hormesis—introducing small stressors to strengthen the body’s resilience. When combined in excess, these ‘small’ stressors accumulate into a significant burden, potentially increasing inflammation rather than reducing it. Sticking to the basics—good nutrition, sleep, and stress management—often has the most profound benefits.
Next Human:Thank you, Paula, for sharing these valuable insights. Where can people learn more about GlycanAge?
Paula: Thank you! People can visit our website or consult with one of our partnered health professionals to learn more about how GlycanAge testing can support their health journey.
Interview with Sofia Shkunnikova – Partner Relations Manager at GlycanAge
,,How glycans play a crucial role in aging, disease prevention, and the future of personalized health?”
Understanding GlycanAge: A Unique Approach to Biological Aging
Next Human: GlycanAge is described as a unique biomarker of biological age. Can you explain in simple terms how it works and how it differs from traditional methods of measuring biological age?
Sophia: Absolutely. GlycanAge is a test that evaluates IgG glycosylation. To understand this, we first need to define glycosylation—it’s a natural modification that happens to most of our proteins, influencing their function. About 60% of our proteins undergo glycosylation, and the specific types of glycans present can give us valuable insights into our biological health.
One important distinction to make is between glycosylation and glycation. While glycosylation is a natural and controlled process, glycation is random damage to proteins, often linked to diabetes and aging. GlycanAge focuses on glycosylation, specifically in immunoglobulin G (IgG), the main protein of our adaptive immune system. By analyzing IgG glycans, we can determine levels of inflammaging—the chronic inflammation that contributes to accelerated aging and disease risk. Unlike traditional biological age tests such as DNA methylation or telomere length, which provide a snapshot of genetic aging, GlycanAge reveals how lifestyle factors are actively shaping your immune system and overall health.
Glycosylation and Aging: A Window into Healthspan
Next Human: What role does glycosylation play in aging, and why is it such a crucial factor in determining healthspan and longevity?
Sophia: Research has shown that IgG glycan patterns change as we age and as chronic inflammation accumulates. This is crucial because inflammaging is one of the key drivers of age-related diseases, from cardiovascular issues to metabolic disorders and autoimmune conditions.
What makes GlycanAge so powerful is its ability to detect these shifts up to 10 years before disease onset. By identifying these patterns early, individuals can take meaningful steps to reverse inflammation and prevent disease progression. Unlike other biomarkers that passively measure aging, GlycanAge provides actionable data, allowing users to actively improve their biological age through lifestyle and health interventions.
Predicting Disease and Optimizing Health with GlycanAge
Next Human: What are some of the most important findings GlycanAge has revealed regarding its ability to predict age-related diseases and health risks?
Sophia: One of the most exciting discoveries is that IgG glycan patterns can indicate disease susceptibility long before symptoms appear. For instance, changes in glycosylation can predict the onset of cardiovascular disease, metabolic disorders, autoimmune conditions, and women’s health issues years in advance.
With this information, individuals can take preventive action—whether it’s through dietary adjustments, exercise modifications, stress management, or medical interventions—to slow down or even halt disease progression.
How to Use GlycanAge: A Simple Yet Powerful Test
Next Human: Can you walk us through the process of taking the GlycanAge test? How easy is it for consumers and healthcare providers to use?
Sophia: When we first started, the test required a full blood sample, making it somewhat cumbersome. Now, we’ve refined the process to a simple at-home finger-prick test, making it accessible to everyone.
Here’s how it works:
- Order the test kit online.
- The kit arrives with everything needed for sampling—lancets, disinfecting wipes, band-aids, and the crucial blood collection card.
- You collect four drops of blood, let them dry, and send the sample back to our lab in Zagreb.
- Our team analyzes the sample, and the results are uploaded to a personalized dashboard.
- The final step—and one of the most important—is the consultation. We offer in-house specialists who help patients interpret their results and provide tailored recommendations to improve their healthspan.
GlycanAge in Clinical Settings and Personalized Medicine
Next Human: Can GlycanAge be used in clinical settings, and do you see it playing a role in the future of personalized medicine?
Sophia: Absolutely! GlycanAge is already being used in over 1,500 clinics worldwide, spanning longevity clinics, HRT specialists, integrative medicine, and functional medicine practices. Clinicians use GlycanAge not only to assess inflammation and biological age but also to track patient progress over time, allowing for continuous adjustments in treatment protocols.
The future of medicine is personalized, preventative, and data-driven. With tools like GlycanAge, we’re moving towards a healthcare system where individuals can monitor their biological aging in real time and make targeted interventions to enhance their longevity and overall well-being.
The Future of Aging Research and GlycanAge’s Vision
Next Human: What excites you the most about the future of aging research, and what can we expect from GlycanAge moving forward?
Sophia: The most exciting part of aging research right now is the growing understanding of how molecular pathways influence aging and how we can manipulate these processes to extend healthspan. We’re learning that aging is not just an inevitable decline but a modifiable process.
GlycanAge aims to be at the forefront of this revolution by continuing to refine its testing technology, expanding clinical applications, and integrating with broader personalized health initiatives. Our vision is to empower people with early detection tools that help them take control of their aging process, allowing them to stay healthier for longer.
Final Thoughts: A Tool for Awareness, Prevention, and Action
Next Human: What do you hope people take away from using GlycanAge? Is it more about awareness, prevention, or motivation for lifestyle changes?
Sophia: It’s a combination of all three. GlycanAge isn’t just a test; it’s a conversation with your future self. It helps people reflect on how their current lifestyle is shaping their biological age and what changes they can make to improve their long-term health.
For some, it’s about awareness—understanding their risks. For others, it’s a preventative tool—helping them take action before diseases manifest. And for many, it’s about motivation—seeing measurable improvements in their biological age through simple, science-backed lifestyle changes.
At the end of the day, aging is inevitable, but how we age is largely in our control. GlycanAge gives us the power to age smarter, healthier, and with greater purpose.
GlycanAge represents a powerful shift towards truly personalized health and longevity. By providing an early, actionable snapshot of biological aging, it empowers individuals to take charge of their health and redefine the way we approach aging in the modern world.
GlycanAge: Unlocking the Future of Personalized Longevity – An Interview with Sophia
In the rapidly evolving field of longevity and precision medicine, GlycanAge stands out as a revolutionary biomarker that provides insight into biological age and overall health. We had the opportunity to speak with Sophia, Partner Relations Manager at GlycanAge, about how glycan-based technology is transforming healthcare and its potential for the future of personalized medicine.
Understanding GlycanAge: A Unique Biomarker
Unlike traditional biological age markers that rely on telomere length or DNA methylation, GlycanAge measures glycosylation patterns on immunoglobulin G (IgG), a key protein of the adaptive immune system. These glycan patterns change with age and reflect levels of chronic inflammation, a critical factor in aging and disease development.
“Glycosylation is a post-translational modification that occurs naturally in our bodies,” Sophia explains. “Around 60% of proteins undergo glycosylation, and its specific patterns can provide valuable insights into an individual’s inflammatory status and biological aging.”
Why GlycanAge Stands Out
One of the major advantages of GlycanAge is its ability to track inflammaging—a chronic, low-grade inflammation that accelerates aging and increases disease risk. By measuring and monitoring glycans, individuals can understand their inflammatory status and make meaningful lifestyle changes to reduce their biological age.
“Compared to other biological age tests, GlycanAge focuses on immune system health and its connection to longevity,” Sophia says. “It’s a dynamic marker, meaning that with the right interventions—like dietary changes, exercise, stress management, and sleep optimization—you can see improvements within 3 to 6 months.”
Predicting and Preventing Age-Related Diseases
GlycanAge isn’t just about tracking aging—it has profound implications for early disease detection and prevention. Studies have shown that changes in glycan patterns can appear up to 10 years before the onset of various diseases, including:
- Cardiovascular diseases
- Metabolic disorders (such as diabetes)
- Autoimmune diseases
- Women’s health issues, including perimenopause and menopause-related changes
“With early detection, individuals can take proactive steps to delay or even prevent disease progression,” Sophia notes. “It’s about empowering people with actionable insights for a longer and healthier life.”
Bringing GlycanAge to Clinical Practice
GlycanAge technology has already been integrated into clinical settings worldwide. With over 1,500 partner clinics, it is used by practitioners in various fields, including:
- Longevity clinics
- Hormone Replacement Therapy (HRT) centers
- Integrative and functional medicine practices
- Preventive healthcare programs
“These clinics use GlycanAge to guide personalized interventions and track patient progress over time,” Sophia explains. “By incorporating it into routine health assessments, clinicians can make informed decisions and adjust treatments based on real-time biological age data.”
A Simple and Accessible Process
GlycanAge has made significant strides in accessibility. Originally requiring a full blood sample, the test now uses a simple finger-prick blood collection kit that can be done at home.
“The process is straightforward,” Sophia says. “You receive a kit with all necessary materials, including lancets, band-aids, and a blood collection card. After collecting a few drops of blood, you send it to our lab, and results are available online within weeks.”
Crucially, GlycanAge doesn’t just provide numbers—it offers expert consultations to help users interpret their results and create personalized action plans for improving their healthspan.
The Future of Glycan-Based Longevity Science
As longevity research advances, glycan-based biomarkers will play an increasing role in precision medicine and preventative healthcare.
“We envision a future where personalized healthcare is truly proactive,” Sophia says. “By understanding and controlling aging at the molecular level, we can intervene much earlier—long before disease develops.”
With ongoing research and expanding clinical applications, GlycanAge is at the forefront of redefining how we measure and manage aging. Whether for individual health optimization or clinical practice, this groundbreaking technology is paving the way for a longer, healthier future.
For more information about GlycanAge and how to test your biological age, visit www.glycanage.com.